| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Departments of Internal Medicine (R.v.C., M.G.N., J.W.M.v.d.M.) and Gastroenterology (C.E.W.), University Medical Center Nijmegen, 6500 HB Nijmegen, The Netherlands; South-East Asian Ministries of Education Organization-Tropical Medicine, Regional Center for Community Nutrition (E.K.), and Working Group on Infectious Diseases, Faculty of Medicine (R.H.H.N.), University of Indonesia, Jakarta, Indonesia; and Division of Human Nutrition and Epidemiology (H.V., C.E.W.), Wageningen University, 6700 HB Wageningen, The Netherlands
Address all correspondence and requests for reprints to: Jos W. M. van der Meer, M.D., FRCP, Professor of Internal Medicine, University Medical Center Nijmegen, P. O Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: j.vandermeer{at}aig.azn.nl
Abstract
Tuberculosis patients often suffer from severe weight loss, which is considered to be immunosuppressive and a major determinant of severity and outcome of disease. Because leptin is involved in weight regulation and cellular immunity, its possible role in tuberculosis-associated wasting was investigated. In an urban clinic in Indonesia, plasma leptin concentrations, indicators of adipocyte mass, appetite, C-reactive protein (CRP), tuberculin reactivity, and cytokine response were measured in tuberculosis patients and healthy controls. Plasma leptin concentrations were lower in patients than in controls (615 vs. 2,550 ng/liter; P < 0.001). Multivariate regression analysis showed that body fat mass and inflammation were two independent factors determining plasma leptin concentrations; there was a positive correlation between fat and leptin, whereas, unexpectedly, leptin was inversely associated with CRP and tumor necrosis factor-
production. Concentrations of both CRP and leptin were independently associated with loss of appetite. Our results do not support the concept that weight loss in tuberculosis is caused by enhanced production of leptin. Rather, loss of body fat leads to low plasma leptin concentrations, and prolonged inflammation may further suppress leptin production. Because leptin is important for cell-mediated immunity, low leptin production during active tuberculosis may contribute to increased disease severity, especially in cachectic patients.
This article has been cited by other articles:
![]() |
D. Ordway, M. Henao-Tamayo, E. Smith, C. Shanley, M. Harton, J. Troudt, X. Bai, R. J. Basaraba, I. M. Orme, and E. D. Chan Animal model of Mycobacterium abscessus lung infection J. Leukoc. Biol., June 1, 2008; 83(6): 1502 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trajman, M. Pai, K. Dheda, R. van Zyl Smit, A. A. Zwerling, R. Joshi, S. Kalantri, P. Daley, and D. Menzies Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur. Respir. J., May 1, 2008; 31(5): 1098 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
A I Martin, E Castillero, M Granado, M Lopez-Menduina, M A Villanua, and A Lopez-Calderon Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis J. Endocrinol., April 1, 2008; 197(1): 111 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kumpers, R. Horn, G. Brabant, A. Woywodt, M. Schiffer, H. Haller, and M. Haubitz Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis Rheumatology, April 1, 2008; 47(4): 484 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Wieland, S. Florquin, E. D. Chan, J. C. Leemans, S. Weijer, A. Verbon, G. Fantuzzi, and T. van der Poll Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice Int. Immunol., November 1, 2005; 17(11): 1399 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Lettow, J. W. M. van der Meer, C. E. West, R. van Crevel, and R. D. Semba Interleukin-6 and Human Immunodeficiency Virus Load, But Not Plasma Leptin Concentration, Predict Anorexia and Wasting in Adults with Pulmonary Tuberculosis in Malawi J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4771 - 4776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Popa, M G Netea, T R D S Radstake, P L van Riel, P Barrera, and J W M van der Meer Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis Ann Rheum Dis, August 1, 2005; 64(8): 1195 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Franchimont, S. Roland, T. Gustot, E. Quertinmont, Y. Toubouti, M.-C. Gervy, J. Deviere, and A. Van Gossum Impact of Infliximab on Serum Leptin Levels in Patients with Crohn's Disease J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3510 - 3516. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gaetke, H. S. Oz, R. C. Frederich, and C. J. McClain Anti-TNF-{alpha} Antibody Normalizes Serum Leptin in IL-2 Deficient Mice J. Am. Coll. Nutr., October 1, 2003; 22(5): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. West, A. Eilander, and M. van Lieshout Consequences of Revised Estimates of Carotenoid Bioefficacy for Dietary Control of Vitamin A Deficiency in Developing Countries J. Nutr., September 1, 2002; 132(9): 2920S - 2926. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |